BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32781778)

  • 1. CD36 and CD97 in Pancreatic Cancer versus Other Malignancies.
    Tanase C; Gheorghisan-Galateanu AA; Popescu ID; Mihai S; Codrici E; Albulescu R; Hinescu ME
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis.
    Heinzelmann K; Lehmann M; Gerckens M; Noskovičová N; Frankenberger M; Lindner M; Hatz R; Behr J; Hilgendorff A; Königshoff M; Eickelberg O
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L682-L696. PubMed ID: 29952218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Kubo M; Gotoh K; Eguchi H; Kobayashi S; Iwagami Y; Tomimaru Y; Akita H; Asaoka T; Noda T; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2020 Feb; 27(2):610-619. PubMed ID: 31605325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: Regulation of Chemoresistance in Pancreatic Ductal Adenocarcinoma by Scavenger Receptor CD36.
    Kubo M; Eguchi H
    Ann Surg Oncol; 2020 Feb; 27(2):620-621. PubMed ID: 31659646
    [No Abstract]   [Full Text] [Related]  

  • 5. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas.
    Aust G; Steinert M; Schütz A; Boltze C; Wahlbuhl M; Hamann J; Wobus M
    Am J Clin Pathol; 2002 Nov; 118(5):699-707. PubMed ID: 12428789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
    Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
    Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.
    Ward Y; Lake R; Martin PL; Killian K; Salerno P; Wang T; Meltzer P; Merino M; Cheng SY; Santoro M; Garcia-Rostan G; Kelly K
    Oncogene; 2013 May; 32(22):2726-38. PubMed ID: 22797060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.
    Pfeiler S; Thakur M; Grünauer P; Megens RTA; Joshi U; Coletti R; Samara V; Müller-Stoy G; Ishikawa-Ankerhold H; Stark K; Klingl A; Fröhlich T; Arnold GJ; Wörmann S; Bruns CJ; Algül H; Weber C; Massberg S; Engelmann B
    FASEB J; 2019 Feb; 33(2):1860-1872. PubMed ID: 30207797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration.
    Ward Y; Lake R; Faraji F; Sperger J; Martin P; Gilliard C; Ku KP; Rodems T; Niles D; Tillman H; Yin J; Hunter K; Sowalsky AG; Lang J; Kelly K
    Cell Rep; 2018 Apr; 23(3):808-822. PubMed ID: 29669286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
    Ward Y; Lake R; Yin JJ; Heger CD; Raffeld M; Goldsmith PK; Merino M; Kelly K
    Cancer Res; 2011 Dec; 71(23):7301-11. PubMed ID: 21978933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy.
    Bhoopathi P; Mannangatti P; Das SK; Fisher PB; Emdad L
    Adv Cancer Res; 2023; 159():285-341. PubMed ID: 37268399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of free fatty acid receptors in periodontal tissues of patients with metabolic syndrome and periodontitis.
    Li G; Robles S; Lu Z; Li Y; Krayer JW; Leite RS; Huang Y
    J Periodontal Res; 2019 Aug; 54(4):356-363. PubMed ID: 30597558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
    Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
    Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer.
    Zhang Z; Qin Y; Ji S; Xu W; Liu M; Hu Q; Ye Z; Fan G; Yu X; Liu W; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):997-1008. PubMed ID: 34117747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 19. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma.
    Yin Y; Xu X; Tang J; Zhang W; Zhangyuan G; Ji J; Deng L; Lu S; Zhuo H; Sun B
    Hepatology; 2018 Nov; 68(5):1865-1878. PubMed ID: 29704239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.